相关实验视频

Updated: May 10, 2025

Dynamic Digital Biomarkers of Motor and Cognitive Function in Parkinson's Disease

Dynamic Digital Biomarkers of Motor and Cognitive Function in Parkinson's Disease

Published on: July 24, 2019

中脑和形铁变化确定了患有REM睡眠行为障碍和帕金森病的患者

Erind Alushaj^1,2, Alan Kuurstra^3,4, Ravi S Menon^3,4

¹Department of Neuroscience, Schulich School of Medicine and Dentistry, Western University, London, ON, Canada.

NPJ Parkinson's disease

|April 23, 2025

概括

异常性REM睡眠障碍 (iRBD) 和帕金森病 (PD) 在黑质体中显示脑铁水平升高. 定量敏感性映射 (QSM) 揭示了白色球体中铁的明显变化,区分了这些条件并提出了潜在的生物标志物.

科学领域:

神经成像是一种神经成像.
神经退行发生神经退行.
生物标志物生物标志物

背景情况:

异常性REM睡眠行为障碍 (iRBD) 是帕金森病 (PD) 的一种前兆形式.
这两种情况都可能共享神经退行性模式,包括改变大脑铁代谢.
定量敏感度映射 (QSM) 是一种敏感的MRI技术,用于检测铁沉积.

研究的目的:

在iRBD和PD患者中使用QSM调查中脑和形铁变化.
探索QSM作为前性PD和早期PD的生物标志物的潜力.
使用QSM来区分iRBD,PD和健康对照 (HCs).

主要方法:

16名iRBD患者,30名PD患者和38名HC患者接受了3T MRI与QSM.
QSM用于量化黑色物质紧部分 (SNc),白色球体 (GPe,GPi) 和腹膜区域 (VTA) 的铁含量.
用于诊断准确性,采用了带有交叉验证的接收器操作特征 (ROC) 曲线分析.

主要成果:

与HC相比,在iRBD和PD组中观察到较高的SNC平均敏感性.
与iRBD和HC相比,PD患者的GPe和GPi平均敏感性降低,与运动严重程度相关.
结合的QSM值准确地区分了iRBD,PD和HC在单个主体层面.

结论:

在SNc,GPe,GPi和VTA中的QSM措施显示出作为调查工具的前景.
QSM可以作为前兆性和早期帕金森病的诊断和进展生物标志物.
由QSM检测到的铁沉积模式可以帮助区分iRBD和PD.

更多相关视频

Standardized Data Acquisition for Neuromelanin-Sensitive Magnetic Resonance Imaging of the Substantia Nigra

Standardized Data Acquisition for Neuromelanin-Sensitive Magnetic Resonance Imaging of the Substantia Nigra

Published on: September 8, 2021

High-resolution Functional Magnetic Resonance Imaging Methods for Human Midbrain

High-resolution Functional Magnetic Resonance Imaging Methods for Human Midbrain

Published on: May 10, 2012

相关概念视频

REM Sleep Behavior Disorder

REM Sleep Behavior Disorder

REM Sleep Behavior Disorder (RBD) is a sleep disorder characterized by the absence of muscle paralysis that normally occurs during the REM phase of sleep. This absence allows individuals to physically act out their dreams, which are often vivid and disturbing. Common behaviors exhibited during episodes include kicking, punching, and yelling. These actions can be dangerous, potentially leading to injuries for the person with RBD or their bed partner.
RBD is significantly associated with...

Parkinson's Disease: Treatment

Parkinson's Disease: Treatment

Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...

Neural Regulation

Neural Regulation

Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.

Parkinson's Disease: Overview

Parkinson's Disease: Overview

Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...